383199-91-5Relevant articles and documents
Development of a pilot-scale preparation of N-[[(5S)-3-[4-(1,1-dioxido-4- thiomorpholinyl)-3,5-difluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide, PNU-288034, an oxazolidinone antibacterial agent
Lu, Cuong V.,Chen, Jiong J.,Perrault, William R.,Conway, Brian G.,Maloney, Mark T.,Wang, Ying
, p. 272 - 277 (2012/12/22)
As part of Pfizer's continuing efforts in the oxazolidinone area, we have developed an efficient synthesis of PNU-288034 and successfully implemented it on pilot scale. The key step was a novel, acid-catalyzed, double Michael addition of 2,6-difluoroanili
N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
-
Page 48, (2010/02/07)
The present invention provides antibacterial agents having the formulae I, II, and III described herein.
N-ARYL-2-OXAZOLIDINONE-5-CARBOXAMIDES AND THEIR DERIVATIVES AND THEIR USE AS ANTIBACTERIALS
-
Page/Page column 92, (2010/02/07)
Compounds of formula B-C-A-CO-NH-R1, wherein A is structure i, ii or iii: formulae (I), (II), (III). C is optionally substituted aryl or heteroaryl, and B is a specified cyclic moiety, or C and B together are a heterobicyclic moiety, are useful as antibacterial agents.